Scientists have discovered a promising new way to predict how well a patient’s heart will recover after a heart attack.
The new method uses an advanced form of PET imaging that allows doctors to see inflammation inside the heart, helping them identify patients at higher risk of poor recovery.
This research, published in The Journal of Nuclear Medicine, could pave the way for earlier and more personalized treatment for heart attack patients.
A heart attack, known medically as acute myocardial infarction (AMI), happens when blood flow to part of the heart is suddenly blocked, cutting off oxygen and causing damage to heart tissue. According to the Centers for Disease Control and Prevention, more than 800,000 Americans experience a heart attack each year.
While many people survive, some develop long-term complications such as heart failure because their heart muscle doesn’t heal properly. Until now, doctors have lacked reliable tools to predict who is most at risk.
The new approach focuses on a protein called CXCR4, which plays an important role in the body’s immune and inflammatory responses.
After a heart attack, inflammation helps clear away damaged cells and begins the healing process—but too much inflammation can harm the heart further. By using PET scans that visualize CXCR4 activity, scientists can now see how much inflammation is happening in the heart and where it’s located.
Dr. Johanna Diekmann and her team at Hannover Medical School in Germany led the study. They wanted to find out if imaging CXCR4 levels could predict how well the heart would heal after a heart attack.
The researchers performed advanced scans—including CXCR4-targeted PET/CT, myocardial perfusion imaging, and cardiac MRI—on 49 patients within the first week after their heart attacks. About eight months later, 40 of those patients returned for follow-up MRI scans to measure their heart function.
The results were eye-opening. The scans showed that CXCR4 activity was not limited to the main area of heart damage but also appeared in the surrounding tissue, known as the border zone.
This was linked to worse heart function later on. In other words, higher inflammation seen early after the heart attack predicted poorer recovery of the heart muscle months later.
These findings highlight the connection between inflammation and how the heart heals. Traditional imaging methods, such as standard MRI or perfusion scans, can show where the heart tissue has been permanently damaged, but they don’t reveal the ongoing inflammation that influences recovery.
By adding CXCR4-targeted PET scans, doctors can now gain valuable information about the healing process itself.
Dr. Diekmann explained that this type of imaging could one day help identify patients whose hearts show excessive or prolonged inflammation after a heart attack.
These patients could then receive targeted anti-inflammatory or regenerative treatments before their condition worsens. The ability to detect these changes early means doctors could act before long-term damage occurs.
This approach also opens doors for more personalized, “precision medicine” treatments for heart attack patients. In the future, nuclear medicine specialists could use this technology not only to diagnose but also to guide and monitor therapies aimed at reducing inflammation and improving heart repair.
In summary, this new CXCR4-targeted PET imaging technique offers a major step forward in understanding how inflammation affects heart recovery after a heart attack. It could help doctors pinpoint patients who need extra care and tailor treatments that prevent heart failure.
While more studies are needed, this breakthrough shows how advanced imaging tools can transform how we predict, monitor, and treat heart disease—bringing new hope for millions of people worldwide.
If you care about heart health, please read studies about a new cause of heart rhythm disorders and eating just one cup of nitrate-rich vegetables daily can reduce heart disease risk.
For more about heart health, please read studies about blood thinners that may not prevent stroke in people with heartbeat problems and this diabetes drug may protect heart health in older veterans.
The study is published in Journal of Nuclear Medicine.
Copyright © 2025 Knowridge Science Report. All rights reserved.
